Actively Recruiting
Study of Diaphragm Movement Using Speckle Tracking During a Spontaneous Breathing Trial in Adults on Mechanical Ventilation
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-05-15
60
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying adult patients who are undergoing mechanical ventilation and preparing to be weaned off the ventilator. The study focuses on evaluating diaphragmatic effort and movement during a spontaneous breathing trial SBT, which involves no assistance from the ventilator. The goal is to explore new ways to assess diaphragm function using diaphragmatic longitudinal strain LSdi and strain rate LSRdi alongside existing measurements, to help detect diaphragmatic dysfunction earlier. Participants will be monitored during a spontaneous breathing trial lasting between 30 and 120 minutes, using continuous positive airway pressure CPAP with zero pressure support. Researchers will measure diaphragm function parameters, including diaphragmatic strain LSdi, LSRdi, thickening fraction TFdi, and airway occlusion pressures 94P0.1 and 94Pocc. These measurements will be taken at baseline before the trial, and then at 2 minutes early, 15 minutes intermediate, and 30 minutes late after the trial starts. During the study, patients will undergo regular assessments of diaphragm function using non-invasive imaging and pressure measurements. The research team aims to monitor changes in diaphragmatic longitudinal strain and strain rate throughout the SBT over a 7-day observation period. This detailed monitoring will help evaluate how the diaphragm performs during weaning from mechanical ventilation. Participants safety and clinical condition will be observed throughout the study period.
CONDITIONS
Brief Title
Diaphragmatic Speckle Tracking During Spontaneous Breathing Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older undergoing mechanical ventilation for at least 24 hours
- Patients eligible for a spontaneous breathing trial
- Ability to trigger ventilator breaths with reasonable assistance
- No severe impairment in gas exchange
- No need for significant hemodynamic support
- Informed consent provided by patient or authorized representative
You will not qualify if you...
- Use of pressure support during the spontaneous breathing trial
- Severe hemodynamic instability (more than 30% increase in vasopressors in last 6 hours or norepinephrine > 0.5 bcg/kg/min)
- Severe or very severe COPD (stage III or IV by GOLD criteria)
- Known or suspected severe or progressive neuromuscular disorder likely to cause prolonged ventilator dependence
- Clinical judgment of attending physician
Research Team
C
Clément Brault, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here